Elizabeth Osborn
Family Medicine · Seneca Falls, NYNPI 1881828457
Payments from drug & device makers
Across 354 payments — averaging $16.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$943
- Pfizer$834
- Novo Nordisk$535
- GSK$392
- Astellas Pharma US Inc$251
- Lilly USA, LLC$206
- plus $3K from 32 others
What the payments were for
- Food & beverage$5,828100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 35 | $943 |
| Pfizer | 69 | $834 |
| Novo Nordisk | 34 | $535 |
| GSK | 29 | $392 |
| Astellas Pharma US Inc | 16 | $251 |
| Lilly USA, LLC | 11 | $206 |
| Amarin Pharma, Inc. | 15 | $201 |
| Bayer | 8 | $194 |
| Novartis | 10 | $178 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $176 |
| Merck | 12 | $167 |
| AbbVie(2 entities) | 8 | $162 |
| Exact Sciences | 8 | $160 |
| Abbott | 8 | $157 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $149 |
| Boehringer Ingelheim | 9 | $146 |
| Amgen | 10 | $142 |
| Teva Pharmaceuticals USA, Inc. | 5 | $111 |
| Johnson & Johnson | 3 | $104 |
| IBSA Pharma Inc. | 5 | $79 |
| Phathom Pharmaceuticals, Inc. | 3 | $62 |
| E.r. Squibb & Sons, L.L.C. | 3 | $48 |
| Kowa Pharmaceuticals America, Inc. | 3 | $48 |
| UCB, Inc. | 2 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Insulet Corporation | 1 | $40 |
| Biohaven Pharmaceuticals, Inc. | 3 | $39 |
| Sanofi-aventis U.S. LLC | 2 | $29 |
| Esperion Therapeutics, Inc. | 2 | $29 |
| Sumitomo Pharma America, Inc. | 2 | $28 |
| Sunovion Pharmaceuticals Inc. | 1 | $21 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $20 |
| Corium, LLC | 1 | $20 |
| Ironwood Pharmaceuticals, Inc | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $16 |
| Eisai Inc. | 1 | $15 |
| Antares Pharma, Inc. | 1 | $14 |
| Nestle Healthcare Nutrition Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$113
How this compares
$5,828 in reported general payments places this provider in the 85th percentile of 4,321 family medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 76 | $84,643 |
| TrulicityDulaglutide | 74 | $77,938 |
| EliquisApixaban | 60 | $74,064 |
| JardianceEmpagliflozin | 44 | $60,059 |
| FarxigaDapagliflozin Propanediol | 43 | $47,282 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 93 | $42,877 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 54 | $33,194 |
| LinzessLinaclotide | 16 | $19,934 |
| InvokanaCanagliflozin | 17 | $19,492 |
| Repatha SureclickEvolocumab | 33 | $18,134 |
| Spiriva RespimatTiotropium Bromide | 22 | $14,918 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 19 | $14,375 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 22 | $13,551 |
| Levothyroxine Sodium | 659 | $10,372 |
| Breo ElliptaFluticasone/Vilanterol | 26 | $10,224 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Spiriva Respimat, Combivent Respimat | $146 | $89,35385 claims |
| GSKAnoro Ellipta, Trelegy Ellipta, Breo Ellipta | $392 | $86,295173 claims |
| Novo NordiskOzempic | $535 | $84,64376 claims |
| Lilly USA, LLCTrulicity | $206 | $77,93874 claims |
| PfizerEliquis, Paxlovid | $834 | $76,84377 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $943 | $63,55979 claims |
| AbbVieLinzess | $162 | $19,93416 claims |
| Johnson & JohnsonInvokana | $104 | $19,49217 claims |
| MerckLagevrio (Eua) | $167 | $9,17413 claims |
| Astellas Pharma US IncMyrbetriq | $251 | $9,13212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,321 family medicine providers in New York.
Other family medicine in Seneca Falls
- Matthew DavisRochester$76.6M
- Frank EderBinghamton$46.2M
- Suchet PatelEndwell$23.3M
- James WildGowanda$2.2M
- Michael FedericoEndwell$1.4M
- Donald BrautigamWestfield$1.3M
- Kimberly DesantisEndwell$1.1M
- Michael TugetmanHartsdale$1M
- Richard RuhOrchard Park$769K
- Eric LorraineEndwell$740K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.